Filing Details

Accession Number:
0001144204-18-054983
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-23 17:04:41
Reporting Period:
2018-10-23
Accepted Time:
2018-10-23 17:04:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1748252 Dd3 Acquisition Corp. DDMX Blank Checks (6770) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754020 Jorge Combe C/O Dd3 Acquisition Corp.
Pedregal 24, Colonia Molino Del Rey
Mexico City O5 11040
Chief Operating Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-10-23 14,125 $0.00 1,676,625 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Warrant Acquisiton 2018-10-23 14,125 $0.00 14,125 $11.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
239,125 No 4 P Indirect
Footnotes
  1. In connection with the underwriters' election to partially exercise the over-allotment option granted in connection with the Issuer's initial public offering, DD3 Mex Acquisition Corp (the "Sponsor") acquired, at a price of $10.00 per unit, 14,125 additional units (the "Private Units") for an aggregate purchase price of $141,250. Each Private Unit consists of one ordinary share and one warrant. This figure does not include an aggregate of up to 4,625 Private Units that the Sponsor has committed to purchase depending on the extent to which the remaining portion of the underwriters' option to purchase additional units is exercised.
  2. Includes an aggregate of up to 46,250 shares subject to forfeiture by the Sponsor depending on the extent to which the remaining portion of the underwriters' option to purchase additional units is exercised.
  3. The securities are held directly by the Sponsor and indirectly by Dr. Martin M. Werner and Jorge Combe, each of whom shares voting power with respect to the Sponsor. Each of Dr. Werner and Mr. Combe disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  4. The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or October 16, 2019.
  5. The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation.